Delek US EVP reports equity grant and tax withholdings

Delek US Holdings EVP Israel Joseph reported equity compensation-related transactions in company common stock.

Rhea-AI Filing Summary

Delek US Holdings EVP Israel Joseph reported equity compensation-related transactions in company common stock. On March 6, he received 4,301 shares as a grant or award, tied to the vesting of performance-based restricted stock units. That same day, 1,693 shares were withheld at $42.29 per share to cover tax obligations on the vesting.

On March 9, an additional 353 shares were withheld at $40.13 per share for tax purposes. After these transactions, Joseph directly held 57,878 shares of Delek US common stock. The dispositions reflect tax-withholding mechanics rather than open-market sales.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Israel Joseph

Role EVP

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	353	$40.13	$14K
Grant/Award	Common Stock	4,301	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,693	$42.29	$72K

Holdings After Transaction: Common Stock — 57,878 shares (Direct)

Footnotes (2)

1. F1. Shares delivered upon the vesting of performance based restricted stock units.
2. F2. Represents shares withheld for tax purposes upon vesting of equity awards.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Delek US (DK) EVP Israel Joseph report?

EVP Israel Joseph reported a stock grant and related tax-withholding dispositions in Delek US common stock. He received 4,301 shares from vesting performance-based restricted stock units and had 2,046 shares withheld across two dates to satisfy tax obligations on these equity awards.

Were Israel Joseph’s Form 4 transactions in DK open-market stock sales?

The reported dispositions were not open-market sales. They were coded as “F” transactions, meaning 2,046 shares were withheld by Delek US to cover tax liabilities related to vested equity awards, a common administrative mechanism rather than discretionary selling in the market.

How many Delek US (DK) shares did EVP Israel Joseph receive as compensation?

He received 4,301 shares of Delek US common stock with a transaction price per share of $0.00, reflecting a grant from vesting performance-based restricted stock units. This equity award increased his direct ownership before subsequent tax-withholding adjustments reduced his net position.

What is Israel Joseph’s Delek US shareholding after these Form 4 transactions?

Following the latest reported transaction, EVP Israel Joseph directly held 57,878 shares of Delek US common stock. This figure reflects the impact of the 4,301-share equity grant and the total 2,046 shares withheld for taxes tied to vesting equity awards during March.

What prices were used for the tax-withholding share dispositions in DK stock?

Tax-withholding dispositions occurred at $42.29 per share for 1,693 shares on March 6 and $40.13 per share for 353 shares on March 9. These prices determine the value of shares surrendered to satisfy tax obligations on the vested equity awards.

What do the footnotes in Israel Joseph’s Delek US Form 4 explain?

The footnotes state that shares were delivered upon vesting of performance-based restricted stock units and that certain shares were withheld for tax purposes. This clarifies that reported dispositions represent administrative tax-withholding events rather than discretionary open-market sales of Delek US stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 08:17 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Israel Joseph

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		A(1)		4,301	A	$0	59,924	D
Common Stock	03/06/2026		F(2)		1,693	D	$42.29	58,231	D
Common Stock	03/09/2026		F(2)		353	D	$40.13	57,878	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares delivered upon the vesting of performance based restricted stock units.

2. Represents shares withheld for tax purposes upon vesting of equity awards.

Remarks:

	/s/ Misty Lavender, Attorney in Fact	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.